The Indian Patent Office's decision to cancel the patent for Novartis's major heart drug, Vymada, has added a new chapter to ...

Patent reforms could address a problem that’s been driving rising prescription drug costs and create a more competitive ...

The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...

Robolaw Corp. relaunched a patent infringement suit alleging a competitor improperly used technology that automates customized legal forms.

Bolstered by funding from Draper Associates, Mighty Capital and The LegalTech Fund, among others, NLPatent plans to add a new ...

Govt proposes amendments to Patent Rules 2003 introducing Code of Conduct, disciplinary procedures, and complaint mechanisms for patent ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind” or the "Company”), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics ...

The U.S. Patent and Trademark Office (USPTO) introduced a new pilot program offering expedited examination for ...

Windtree has a total of 59 issued or allowed patents and 17 pending patents for Istaroxime and its SERCA2a activators ...

The United States Patent and Trademark Office (USPTO) recently announced the Streamlined Claim Set Pilot Program, designed to speed up examination.

NEW CANAAN, CT / ACCESS Newswire / November 6, 2025 / Network-1 Technologies, Inc. (NYSE American:NTIP), a company specializing in the acquisition, development, licensing, and monetization of its ...

GOTHENBURG, Sweden, November 13 2025 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the European Patent Office (EPO) has issued an Intention to Grant notice regarding a n ...